John Reilly

John Reilly kicks off the session on precision ARDS with Identifying Treatable Traits and Examining Heterogeneity of Treatment Effect in Critical Care Trials #ats2025 #ATSCritCareLive  @ATS_Assemblies @atscommunity

📣 #journal_CHESTCritCare, volume 3, issue 1 has landed 🛬 chestcc.org/current 👀 Check out the: ⭐️ 3 editorials ⭐️ 14 original research / research letters ⭐️ 2 CHEST CC reviews ⭐️ 2 How I Do Its All #OpenAccess, all the time.

In an unprecedented move, the US National Institutes of Health has begun mass terminations of research grants that fund active scientific projects because they no longer meet “agency priorities”. go.nature.com/4i2EaIb

Hangjng out with the superfun #journal_ChestCritCare crew! @journal_CHEST @HBGMD @John_P_Reilly @ErinCarlton

Do not obey in advance. Lesson 1, first page, of my pamphlet "On Tyranny"

🤰Views differ, but many worry new laws in the US may ⬆️ pregnant/post-partum patients in our ICUs… So, it’s timely that Kolbe, @DesertFox1976, et al evaluate lactation practices 🍼 in ICU… chestcc.org/article/S2949-… 🛑 Spoiler alert — we could do better #journal_CHESTCritCare

Read our latest issue in full ➡️ bit.ly/42Pq2wX

🤯 As cancer treatment advances, ICU clinicians must stay up-to-date on caring for complications… Just out in #journal_CHESTCritCare, @KMonty_MD, @DrGhanbar, et al explain how to manage immune checkpoint inhibitor pneumonitis in ICU: 💉🫁 chestcc.org/article/S2949-…

💊 Tylenol to treat headaches & fevers… but sepsis? 🦠 Just out in #journal_CHESTCritCare, Obeidalla & colleagues provide compelling data suggesting further study is warranted: chestcc.org/article/S2949-… #OpenAccess

☹️ Just as I was feeling sad that #CHEST2024 is coming to an end… Walker, Yarnell, et al’s new study ?ing how race/ethnicity/sex associate w use of ICU sedation in #journal_CHESTCritCare (just out today) has made me 😃 chestcc.org/article/S2949-…

🎂 Happy 1st birthday, #journal_CHESTCritCare! As Vol 2, Iss 2 drops today, we are a year into our journey… 🚗 …& oh how we’ve grown! ⭐️ 16 original research articles ⭐️ 2 HIDIs/reviews ⭐️ 1 case series ⭐️ 6 editorials 👀 Check it out at: chestcc.org/current

@eemoin So true!

So incredibly proud of #EnoEssien. Recent alumni and winner of ATS Bear Cage 2024 for her nanoparticles for ARDS therapy. Such impressive work and such an impressive woman. Keep an eye on her - she is going to go far! @PennPulmonary #ATS2024 @atscommunity

Former chief fellow @R_M_Bennett presenting a latent class analysis that identified 2 endotypes of respiratory failure in sepsis. Such a great start to her research career! @PennPulmonary #ATS2024

Such great support by @PennPulmonary fellows for fellows (and one faculty member @mpkerlin). Love the community! #ATS2024 @atscommunity

#ATS2024 @ATSCritCare great discussions about improving sepsis and pneumonia trials and patient-oriented research at A23 “Investigating Heterogeniety” - host factors vs pathogen factors, ensuring trial representativeness @John_P_Reilly @KitsiosMd Dr. Claire Shappell

I’m going to #ATS2024 tomorrow. I’m sitting here googling “do people say ARDSSS or A-R-D-S?” I’m too much of an ophthalmologist for this.

Congratulations to the 3 finalists of the BEAR Cage competition! Dr. Essien Dr. Huapaya and Dr. Milled! Mark your calendars for May 20, 2024, from 1:30 - 3:30p.m. and cheer on our three finalists 📍Exhibit Hall G, Innovation Theater #ATS2024 #MedEd #SharkTank